Literature DB >> 10535339

Clinical application of maternal serum cytokine determination in premature rupture of membranes--interleukin-6, an early predictor of neonatal infection?

K A Pfeiffer1, J Reinsberg, A Rahmun, J Schmolling, D Krebs.   

Abstract

BACKGROUND: In cases of premature rupture of membranes (PROM), an early detection of fetal infection is necessary in order to weigh infectious complications against prematurity. As routine parameters (leukocytes, C-reactive protein (CRP), fever, and fetal tachycardia) lack satisfactory sensitivity and specificity, this study evaluates whether the determination of interleukin-6 (IL-6), interleukin-8 (IL-8) or soluble interleukin-2 receptor (IL-2R) in maternal serum could supplement or replace routine inflammation parameters.
METHODS: In this prospective study results of clinical and laboratory parameters were investigated with respect to neonatal infection in 71 patients with PROM. IL-6, IL-8 and IL-2R were determined by enzyme immunoassays.
RESULTS: Best specificity and sensitivity could be demonstrated for CRP and IL-6. Both elevation of CRP and IL-6 correlated significantly (p<0.01 and p<0.001, respectively) with the onset of neonatal infection. At a cutoff of 11 pg/ml, IL-6 reaches a sensitivity of 81% and a specificity of 76%; CRP a specificity of 76% (cutoff 1.2 mg/dl) and a sensitivity of 56%. In 4/16 (25%) cases developing neonatal infection, IL-6 increased earlier than CRP. IL-8 and IL-2R results showed a less significant correlation with fetal outcome.
CONCLUSIONS: Determination of IL-6 in maternal serum can significantly contribute to an earlier detection of fetal infection in patients with PROM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535339

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  7 in total

1.  The antibiotic treatment of PPROM study: systemic maternal and fetal markers and perinatal outcomes.

Authors:  Brian M Mercer; Dennis T Crouse; Robert L Goldenberg; Menachem Miodovnik; Delicia C Mapp; Paul J Meis; Mitchell P Dombrowski
Journal:  Am J Obstet Gynecol       Date:  2011-09-08       Impact factor: 8.661

Review 2.  Inflammatory markers in cord blood or maternal serum for early detection of neonatal sepsis-a systemic review and meta-analysis.

Authors:  H Su; S-S Chang; C-M Han; K-Y Wu; M-C Li; C-Y Huang; C-L Lee; J-Y Wu; C-C Lee
Journal:  J Perinatol       Date:  2014-01-23       Impact factor: 2.521

3.  Role of interleukin-6 in mortality from and physiologic response to sepsis.

Authors:  Daniel G Remick; Gerald Bolgos; Shannon Copeland; Javed Siddiqui
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth <32 weeks and adverse neonatal outcomes.

Authors:  Yoram Sorokin; Roberto Romero; Lisa Mele; Ronald J Wapner; Jay D Iams; Donald J Dudley; Catherine Y Spong; Alan M Peaceman; Kenneth J Leveno; Margaret Harper; Steve N Caritis; Menachem Miodovnik; Brian M Mercer; John M Thorp; Mary Jo O'Sullivan; Susan M Ramin; Marshall W Carpenter; Dwight J Rouse; Baha Sibai
Journal:  Am J Perinatol       Date:  2010-03-01       Impact factor: 1.862

5.  Association of inflammatory and angiogenic biomarkers in maternal plasma with retinopathy of prematurity in preterm infants.

Authors:  Jae Shin Song; Se Joon Woo; Kyo Hoon Park; Hunmin Kim; Kyong-No Lee; Yu Mi Kim
Journal:  Eye (Lond)       Date:  2022-09-15       Impact factor: 4.456

6.  Positive maternal C-reactive protein predicts neonatal sepsis.

Authors:  Ji Hyun Jeon; Ran Namgung; Min Soo Park; Koo In Park; Chul Lee
Journal:  Yonsei Med J       Date:  2014-01       Impact factor: 2.759

7.  Maternal white blood cell count cannot identify the presence of microbial invasion of the amniotic cavity or intra-amniotic inflammation in women with preterm prelabor rupture of membranes.

Authors:  Ivana Musilova; Lenka Pliskova; Romana Gerychova; Petr Janku; Ondrej Simetka; Petr Matlak; Bo Jacobsson; Marian Kacerovsky
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.